Little consistency in price changes of top billed drugs under ASP
Now in its ninth year, CMS’ methodology of average sales price (ASP) plus 6% for paying for Part B covered drugs often results in pretty big price shifts, even from one quarter to the next.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.